Search

The EMA regulates the availability of medicines across all 27 European Union Member States as well as Iceland, Norway, and Liechtenstein.

The discussions focused on developing a regional policy brief for the promotion, protection and restoration of mental health in older adults, with the inclusion of a focus on dementia awareness and risk reduction. 

ADI and ADI Member, Febraz, participated in a public hearing held by the Human Rights Commission at the Brazilian Federal Senate, to debate public policies for the care of people living with dementia

During the 60-minute meeting, the advisory panel discussed ADI's activities over the last year, as well as proposals for future avenues of research, including a working group to explore the impact of COVID-19 as a potential risk factor for accelerating dementia.

To date, only 37 of 194 countries that signed up to implement the WHO Global action plan on dementia have created and funded national dementia plans. Our new campaign aims to galvanise and encourage more governments to develop national dementia plans following their 2017 commitment.

Dementia design in built environment is 30 years behind physical disabilities movement ADI calls on governments to embed design in their national dementia responses under the Convention on the Rights for Persons with Disabilities Dementia design follows simple principles, is cost effective and dramatically improves enjoyment and safety of built environment…

‘Dementia Innovation Readiness Index 2020: 30 Global Cities’ calls strongly for cities to fulfil their commitments under the WHO’s Global action plan on dementia to engage fully with their national dementia plans.

This November, African regional members from across the continent including Botswana, Burundi, Cameroon, Ethiopia, France, Ghana, Kenya, Madagascar, Mauritius, Nigeria, Sénégal, South Africa, Uganda and Zimbabwe, convened in…

ADI, alongside Newcastle University and the London School of Economics, is submitting an application to the WHO Expert Committee on the inclusion of anti-dementia medication and needs to hear from clinicians everywhere.

Read the most frequently asked questions around World Alzheimer’s Month, including when is it and why is it important.